scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M701141200 |
P698 | PubMed publication ID | 17439953 |
P50 | author | Ko Fujimori | Q39066313 |
P2093 | author name string | Kosuke Aritake | |
Yoshihiro Urade | |||
P2860 | cites work | Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target | Q42832702 |
Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis | Q44703208 | ||
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans | Q44904582 | ||
Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients | Q45027226 | ||
Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice | Q46560412 | ||
Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha | Q47934135 | ||
Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides. | Q54615368 | ||
Role of LXRs in control of lipogenesis | Q24290548 | ||
Obesity and insulin resistance | Q24607078 | ||
Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter | Q28570239 | ||
Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors | Q28571146 | ||
Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase | Q28572884 | ||
Global and societal implications of the diabetes epidemic | Q29614551 | ||
Obesity and the regulation of energy balance | Q30080025 | ||
Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. | Q30478455 | ||
Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5'-flanking region and the AP-2 element in the untranslated exon 1. | Q33918650 | ||
Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes | Q34121545 | ||
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism | Q34284209 | ||
Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. | Q34451430 | ||
An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion | Q34509691 | ||
Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. | Q35748577 | ||
Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation | Q36694542 | ||
Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression | Q37277355 | ||
Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid | Q37728908 | ||
Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain | Q38295909 | ||
Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells | Q38359652 | ||
Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase | Q40302517 | ||
Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. | Q40459310 | ||
Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues | Q40667304 | ||
Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. | Q41130960 | ||
Expression of NADP+-dependent 15-hydroxyprostaglandin dehydrogenase mRNA in monkey ocular tissues and characterization of its recombinant enzyme | Q42671170 | ||
On the role of liver X receptors in lipid accumulation in adipocytes | Q42805825 | ||
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins | Q42806855 | ||
A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. | Q42811809 | ||
ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism | Q42813608 | ||
Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. | Q42818414 | ||
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adipocyte | Q357519 |
P304 | page(s) | 18458-18466 | |
P577 | publication date | 2007-04-17 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c | |
P478 | volume | 282 |
Q36135903 | Aldo-Keto Reductases 1B in Endocrinology and Metabolism |
Q42581400 | Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase |
Q34452830 | Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice |
Q24630614 | Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis |
Q34574376 | Expression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis |
Q33781016 | Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis |
Q35018078 | High-Quality Protein Crystal Growth of Mouse Lipocalin-Type Prostaglandin D Synthase in Microgravity |
Q61796391 | L-PGDS-produced PGD in premature, but not in mature, adipocytes increases obesity and insulin resistance |
Q28506812 | NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity |
Q28586698 | Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade |
Q45417013 | Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells |
Q39449759 | Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase |
Q43171502 | Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. |
Q35129193 | Prostaglandin (PG) F2 alpha synthesis in human subcutaneous and omental adipose tissue: modulation by inflammatory cytokines and role of the human aldose reductase AKR1B1. |
Q94686849 | Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix |
Q28509544 | Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity |
Q41873873 | Prostaglandins as PPARγ Modulators in Adipogenesis |
Q36920540 | Retinol and retinyl esters: biochemistry and physiology |
Q89612196 | Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice |
Q42803031 | Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids |
Q27643949 | Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase |
Q39615733 | Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase |
Q34412709 | Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α. |
Q37173360 | Transcriptional regulation of adipocyte formation by the liver receptor homologue 1 (Lrh1)-Small hetero-dimerization partner (Shp) network |
Search more.